Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the ...

Moreover, the FDA cleared Tempus’ xT CDx. This is a 648-gene tumor profiling test. The FDA also cleared its ECG-AF algorithm, which is used for cardiac risk assessment. CMS followed by approving ...

On December 17, 2024, Tempus announced that the Centers for Medicare and Medicaid Services will allow reimbursement for assessments of cardiac dysfunction using the Tempus ECG-AF algorithm.

We recently compiled a list of the 10 Firms Lead Thursday's Rally on Better Earnings, Bargain-Hunting. In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands ...

Tempus AI, Inc (NASDAQ:TEM) is soaring as investors get behind former House Speaker Nancy Pelosi's latest stock purchase. Yet, as we go through and discuss the setup here, I contend that investors ...

Tempus AI shares were up 18.0% at $41.48 at the time of publication Tuesday, according to Benzinga Pro.

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

Tempus Ai got a big valuation boost following a disclosure that Nancy Pelosi had purchased call options for the stock. The healthcare AI company also unveiled its new software service today. In a ...

Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM provides next generation sequencing diagnostics, polymerase chain ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

Tempus AI was one of them. Pelosi purchased 50 call options with a strike price of $20 that also expire on Jan. 16, 2026. The value of the trade was between $50,000 and $100,000.